Teva Invites the Public to Listen to Its 2012 Investor Meeting Webcast Business Wire JERUSALEM -- December 06, 2012 Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) invites investors and the general public to listen to a live audio webcast of its 2012 Investor Meeting on Tuesday, December 11, 2012 at 12:00 p.m. ET. What: Teva’s 2012 Investor Meeting Who: Teva Management When: Tuesday, December 11, 2012 at 12:00 p.m. ET Where: www.tevapharm.com Live over the Internet -- log on to the Web at the address above How: and register for the event (approx. 10 minutes before). An archive of the webcast will be available on Teva's website. About Teva Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Headquartered in Israel, Teva is the world's leading generic drug maker, with a global product portfolio of more than 1,300 molecules and a direct presence in about 60 countries. Teva's branded businesses focus on CNS, oncology, pain, respiratory and women's health therapeutic areas as well as biologics. Teva currently employs approximately 46,000 people around the world and reached $18.3 billion in net revenues in 2011. Contact: IR: Kevin C. Mannix United States 215-591-8912 Joseph Marczely United States 267-468-4281 Tomer Amitai Israel 972 (3) 926-7656 or PR: Hadar Vismunski-Weinberg Israel 972 (3) 926-7687 Denise Bradley United States 215-591-8974
Teva Invites the Public to Listen to Its 2012 Investor Meeting Webcast
Press spacebar to pause and continue. Press esc to stop.